Immunosuppressive drugs. I.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000818:Animals; D000906:Antibodies; D000917:Antibody Formation / Q000187:drug effects; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000188:drug therapy; D007111:Immunity, Cellular / Q000187:drug effects; D007136:Immunoglobulins / Q000096:biosynthesis; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy; D016038:Skin Transplantation; D014181:Transplantation Immunology / Q000187:drug effects
D000305:Adrenal Cortex Hormones; D000906:Antibodies; D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D007136:Immunoglobulins; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001379:Azathioprine; D008727:Methotrexate